H1N1 in Households, or the Math of Spreading Swine Flu

Conclusions from the Statistical Study of the 2009 Spread of H1N1 Swine Flu in Birmingham

A sneezing girl could transmit H1N1 : Image by SCA Svenska Cellulosa Aktiebolaget

The statistics led to three major conclusions, each with several facets.

First, this statistical model does indeed make it possible to estimate how thoroughly an infectious disease will spread through a household. This should guide clinical decisions about preventative measures within households, and perhaps at school or in the workplace as well.

However, the true number of cases will likely be somewhere between those found by laboratory testing and what doctors merely suspect from clinical evaluation of symptoms. Moreover, the lab tests might provide false negative tests due to improper swabbing or other issues.

The second conclusion was that swine flu transmission rates are quite variable. In two-person households, more often both people were ill than just one. Larger households most often had only one person fall ill; fewer had every person sick; and fewer still had some intermediate number of patients, but this study was not constructed to determine why some households were more completely stricken than others.

The final and most significant result found that a mathematical model can complement time-consuming laboratory work. The parameters of a new pandemic should be determined “early in an epidemic of something new,” as Dr. House hopes. Then, clinical practice can adapt to the severity and transmissibility of the outbreak. The statistics can help make health care delivery more efficient and more effective during a future pandemic.


Decoded Science asked Dr. House how many households would be required to identify an incipient epidemic, and he replied, “Others in the literature have done simpler analyses on much smaller datasets, and got reliable estimates but with large uncertainty. The method should not be biased, so the same will hold: more data means less uncertainty, but the method does not require some minimum amount of data to work (technically, it does not rely on asymptotically large amounts of data)“.

Future studies could examine disease transmissibility by age, as well as the effectiveness of increased hand-washing versus anti-viral medications.

Click to Read Page Three: Mathematical Methods for H1N1 Transmission Study

Pages: 1 2 3

  • Gord5467

    I was with the Canadian Forces in 2009, was ordered to get the H1N1 shot (AREPANRIX by GSK GlaxoSmithKline) and had an adverse reaction to the vaccine. I received PERMANENT neurological, cardiovascular, gastrointestinal, and respiratory symptoms: dizziness, vertigo, irregular heart rhythms, shortness of breath, muscle weakness and pain, and numbness in hands and feet. My physical fitness changed from special forces fit to that of a 70 year old in a matter of days. Prior to the vaccination the Department of National Defence (DND) provided information advising side effects “having mild chills and fever a few days following the shot means it is working”, and “There is a 1 in 1,000,000 chance of acquiring a serious neurological complication”. According to GSKs product information provided by Health Canada, “neurological disorders” are “very rare (may occur with up to 1 in 10,000 doses)” and “if any of these side effects occur, please tell your doctor or nurse immediately” which differs from the information provided to soldiers. The DND also stated “It is not a live vaccine so it cannot give you the flu”. According to Dr. Danuta Skowronski, an epidemiologist and an influenza expert at the B.C. Centre for Disease Control, “In the early weeks of the pandemic that people who got the flu shot (H1N1) for 2008-09 winter seemed to be more likely to get infected with the pandemic virus than people who hadn’t received the shot”. Another study linked narcolepsy, a neurological disorders to the H1N1 vaccine, “Narcolepsy in association with pandemic influenza vaccination”, September 2012, European Centre for Disease Prevention and Control. You may also query the National Vaccine Information Center database of adverse reactions to vaccines (VAERS) which includes more than 11,465 events (adverse reactions) to the H1N1 vaccine, 3,390 symptoms and 61,500 reactions (more than 5 reactions per record). In the UK, the “FINAL PUBLIC SUMMARY – UK Suspected Adverse Reaction Analysis, Swine Flu (H1N1) Vaccines – Celevanpan and Pandemrix, 26 March 2010″ details more than 8,600 suspected reactions classified into 650 reaction names. Other information to consider is from Richard Warrington, President of the Canadian Society of Allergy and Clinical Immunology, “Vaccination with Arepanrix has led to far more reports of anaphylaxis or significant allergic reactions than is normally expected for a flu vaccine.” You may also ask your doctor and other Health care workers if they received the H1N1 vaccination and if they plan to remain up to date with all vaccinations. Reports from Canada, US, India, Hong Kong and other countries note a 50% vaccination rate among those who recommend and administer the immunization. According to Fox News “Most said they would pass on the H1N1 shot … because they were afraid of side effects and doubted how safe and effective it would be.” I asked my doctor and he didn’t hesitate in saying “no way”. Be informed and please choose wisely if you do plan to have your next flu shot or vaccination.